Question 1

Does Ubs own KAPA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 6,261 shares of KAPA (Kairos Pharma), worth $2,404.

Question 2

How many shares of KAPA does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 6,261 shares of KAPA (Kairos Pharma).

Question 3

What is Ubs' KAPA position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' KAPA position is worth $2,404.

Question 4

Is Ubs buying or selling KAPA?

Accepted Answer

In Q2 2026, Ubs opened a new KAPA position of 6,261 shares.

Question 5

When did Ubs first buy KAPA?

Accepted Answer

Ubs first reported KAPA in its Q4 2024 13F and has listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	6,261	-	$2,404	0.0%	$2.69	19
2025-Q4	Exited	0	-100.0%	$0	0.0%	$4.97	0
2025-Q3	Decreased	5,979	-36.8%	$6,995	0.0%	$8.19	0
2025-Q2	Increased	9,458	+238.8%	$6,706	0.0%	$4.96	18
2025-Q1	Decreased	2,792	-74.3%	$2,613	0.0%	$6.55	0
2024-Q4	New	10,845	-	$16,484	0.0%	$10.64	28

KAPA6 quarters

KAPA
6 quarters